Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease

Liver Int. 2019 Oct;39(10):1884-1894. doi: 10.1111/liv.14184. Epub 2019 Jul 10.

Abstract

Background & aims: Little is known about the impact of metabolically healthy obesity on fibrosis progression in non-alcoholic fatty liver disease (NAFLD). We investigated the association of body mass index (BMI) category, body fat percentage and waist circumference with worsening of noninvasive fibrosis markers in metabolically healthy and unhealthy individuals with NAFLD.

Methods: A cohort study was performed on 59 957 Korean adults with NAFLD (13 285 metabolically healthy and 46 672 metabolically unhealthy individuals) who were followed for a median of 7.7 years. Being metabolically healthy was defined as not having any metabolic syndrome component and having a homoeostasis model assessment of insulin resistance <2.5. Progression from low to intermediate or high probability of advanced fibrosis was assessed using the NAFLD fibrosis score (NFS).

Results: During 339 253.1 person-years of follow-up, 9857 subjects with low NFS at baseline progressed to intermediate or high NFS. Among metabolically healthy individuals, the multivariable-adjusted HRs (95% CI) for NFS worsening comparing BMIs 23-24.9, 25-29.9 and ≥30 with a BMI of 18.5-22.9 kg/m2 were 1.19 (1.00-1.42), 1.79 (1.52-2.10) and 3.52 (2.64-4.69), respectively, whereas the corresponding HRs (95% CI) in metabolically unhealthy individuals were 1.37 (1.24-1.52), 2.18 (1.99-2.39) and 4.26 (3.83-4.75). A similar trend was observed in the analyses using body fat and waist circumference.

Conclusion: In the large-scale cohort of young and middle-aged individuals with NAFLD, BMI was positively associated with worsening of noninvasive fibrosis marker regardless of metabolic health status. Excess adiposity per se, even without accompanying metabolic health status, may contribute to fibrosis progression in NAFLD.

Keywords: cohort study; metabolic health; non-alcoholic fatty liver disease; obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Mass Index
  • Case-Control Studies
  • Cohort Studies
  • Disease Progression
  • Female
  • Health Status
  • Humans
  • Insulin Resistance
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / pathology*
  • Male
  • Non-alcoholic Fatty Liver Disease / complications*
  • Obesity / pathology*
  • Obesity, Metabolically Benign / pathology*
  • Republic of Korea
  • Risk Factors
  • Waist Circumference